Autonomix's targeted ablation therapy improved symptoms, functionality, and quality of life in severe pancreatic cancer patients, especially those with stage 4 disease. Rapid pain relief and durable ...

Real-world outcomes of durvalumab or pembrolizumab plus gemcitabine and cisplatin (GemCis) in advanced biliary tract cancer (BTC). Efficacy and safety of first-line chemotherapy in elderly patients ...

Quantum, developer of the Epione robotic platform for cancer treatment, said the acquisition supports its strategy of reducing cancer mortality through robot-assisted tumor ablation.

Earlier analyses demonstrated strong local tumor control, with nearly nine in 10 patients remaining free of recurrence at ...

July 19, 2006 –- Patients with early-stage non–small cell lung cancer who are not candidates for surgery now have other noninvasive and potentially lifesaving options. In a paper published in the July ...

Add Yahoo as a preferred source to see more of our stories on Google. Francis Medical’s Vanquish device for treating intermediate-risk prostate cancer has been cleared by the US Food and Drug ...

SynergyMed Achieves Major 2025 Milestones, Advancing Toward Commercialization of Noninvasive Thermal Ablation Cancer ...

The phase 2 ProFocal Laser Therapy for Prostate Tissue Ablation (PFLT-PC) trial tested a cooled laser focal therapy device for intermediate-risk prostate cancer treatment.

AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options ...

Quantum Surgical has acquired NeuWave Medical, a microwave ablation technology developer previously acquired by Johnson & Johnson.

The average age of men who get diagnosed is 67.